Home The Active Ingredient Matrix Desmodium adscendens (Soyasaponin I)

Formulation Intelligence

Desmodium adscendens (Soyasaponin I)

Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Desmodium adscendens (Soyasaponin I).

Desmodium adscendens functions as a potent hepatoprotective and spasmolytic agent by modulating the arachidonic acid cascade and inhibiting the release of histamine and leukotrienes via its triterpenoid saponin fraction.

Verified Molecular Profiling (NIH PubChem)

PubChem CID

122138

Molecular Weight

862.8 g/mol

XLogP3 (Lipophilicity)

0.9

IUPAC Name

3-[7,13,17-tris(2-carboxyethyl)-3,8,12,18-tetrakis(carboxymethyl)-3,8-dimethyl-2,7,23,24-tetrahydroporphyrin-2-yl]propanoic acid

Pharmacokinetic Synergies & Enhancers

Proven Synergy Pairings

  • Milk Thistle (Silybum marianum) for enhanced hepatocyte membrane stabilization and antioxidant regeneration.
  • Boswellia serrata for synergistic inhibition of 5-lipoxygenase (5-LOX) in respiratory inflammatory pathways.

Biological Formulation Enhancers

  • Piperine for increasing intestinal permeability and inhibiting P-glycoprotein-mediated efflux of triterpenoid glycosides.
  • Quercetin for potential inhibition of phase II metabolism enzymes, extending the half-life of circulating saponins.

Delivery System Constraints & Modeling

Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Desmodium adscendens (Soyasaponin I) across standard consumer modalities.

💊 Standard Capsules

The hygroscopic nature of concentrated Desmodium extracts requires moisture-barrier HPMC capsules to prevent clumping and maintain flowability during high-speed encapsulation.

🍬 Gummy & Pectin Formats

The inherent bitterness and saponin-induced foaming properties necessitate advanced masking agents and pH control to prevent pectin matrix degradation and off-flavors.

🔬 Thin-Film Oral Strips

High therapeutic dosage requirements for Desmodium extracts often exceed the 50mg payload capacity of standard thin-film polymers, risking film brittleness and structural failure.

For Brand Founders

Formulate with Desmodium adscendens (Soyasaponin I)

Ready to launch a product featuring Desmodium adscendens (Soyasaponin I)? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.

Build Science-Backed Formulation

Efficacy Evidence

Maximize Desmodium adscendens (Soyasaponin I) Bioavailability

Need absolute proof that your Desmodium adscendens (Soyasaponin I) extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.

Simulate Bioavailability

For R&D Labs & CDMOs

Desmodium adscendens (Soyasaponin I) Degradation Testing

Is your Desmodium adscendens (Soyasaponin I) payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.

Model Active Degradation